pumitamig (BNT327) - BioNTech, BMS
The PD-L1×VEGF-A bispecific antibody pumitamig shows enhanced binding to PD-L1 upon complexation with VEGF-A, promoting PD-L1 internalization and degradation in tumor cells (SITC 2026) - Oct 2, 2026 - Abstract #898; Pres time: Nov 7, 2026; 10:00 AM - 08:10 PM; Location: PCC - Lower Level - North Exhibition Halls 4-5-6; No abstract available 
Bispecific • Tumor cell • Oncology
https://www.sitcancer.org/2026/abstracts/titles-and-publications?SITC%202026%20Abstracts%5BhitsPerPage%5D=100
 
Tonya Kueck; Jan Bogen; Amanda Moore; Maren Köhne; Junying Chen; Efthymios Karpouzis; Aras Toker; Ilhan Celik; Claudia-Nanette Gann; Hans-Ulrich Schmoldt; Andy Tsun; Joycelyn Wüstehube-Lausch; Lynda Groocock; Özlem Türeci; Yi Luo; Alexander Muik; Ugur Sahin
 
Oct 2, 2026
 
Prev Next